{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:33:24Z","timestamp":1790836404787,"version":"4.1.0"},"reference-count":65,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"H2020 ONCOBIOME","award":["N\u00b0825410"],"award-info":[{"award-number":["N\u00b0825410"]}]},{"name":"Germano-French ANR Ileobiome","award":["19-CE15-0029-01"],"award-info":[{"award-number":["19-CE15-0029-01"]}]},{"name":"NIH","award":["NCI P01 CA250927"],"award-info":[{"award-number":["NCI P01 CA250927"]}]},{"name":"AMMICa","award":["US23\/CNRS UMS3655"],"award-info":[{"award-number":["US23\/CNRS UMS3655"]}]},{"DOI":"10.13039\/501100018872","name":"LabEx Immuno-Oncology","doi-asserted-by":"crossref","award":["ANR-18-IDEX-0001"],"award-info":[{"award-number":["ANR-18-IDEX-0001"]}],"id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"crossref"}]},{"name":"RHU Torino Lumi\u00e8re","award":["ANR-16-RHUS-0008"],"award-info":[{"award-number":["ANR-16-RHUS-0008"]}]},{"name":"French Government\u2019s Investissement d\u2019Avenir","award":["ANR-10-LABX-69-01"],"award-info":[{"award-number":["ANR-10-LABX-69-01"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2022,1,8]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prostate cancer (PC) responds to androgen deprivation therapy (ADT) usually in a transient fashion, progressing from hormone-sensitive PC (HSPC) to castration-resistant PC (CRPC). We investigated a mouse model of PC as well as specimens from PC patients to unravel an unsuspected contribution of thymus-derived T lymphocytes and the intestinal microbiota in the efficacy of ADT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Preclinical experiments were performed in PC-bearing mice, immunocompetent or immunodeficient. In parallel, we prospectively included 65 HSPC and CRPC patients (Oncobiotic trial) to analyze their feces and blood specimens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In PC-bearing mice, ADT increased thymic cellularity and output. PC implanted in T lymphocyte-depleted or athymic mice responded less efficiently to ADT than in immunocompetent mice. Moreover, depletion of the intestinal microbiota by oral antibiotics reduced the efficacy of ADT. PC reduced the relative abundance of <jats:italic>Akkermansia muciniphila<\/jats:italic> in the gut, and this effect was reversed by ADT. Moreover, cohousing of PC-bearing mice with tumor-free mice or oral gavage with <jats:italic>Akkermansia<\/jats:italic> improved the efficacy of ADT. This appears to be applicable to PC patients because long-term ADT resulted in an increase of thymic output, as demonstrated by an increase in circulating recent thymic emigrant cells (sjTRECs). Moreover, as compared with HSPC controls, CRPC patients demonstrated a shift in their intestinal microbiota that significantly correlated with sjTRECs. While feces from healthy volunteers restored ADT efficacy, feces from PC patients failed to do so.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings suggest the potential clinical utility of reversing intestinal dysbiosis and repairing acquired immune defects in PC patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2021-004191","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T12:12:22Z","timestamp":1647432742000},"page":"e004191","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":67,"title":["Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9138-2272","authenticated-orcid":false,"given":"Safae","family":"Terrisse","sequence":"first","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"},{"name":"Medical Oncology, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Gaelle","family":"Goubet","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Urology, Kurume University School of Medicine, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Maltez","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department CIBIO, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Quiniou","sequence":"additional","affiliation":[{"name":"Parean Biotechnologies, Saint Malo, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Thelemaque","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garett","family":"Dunsmore","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5039","authenticated-orcid":false,"given":"Emmanuel","family":"Clave","sequence":"additional","affiliation":[{"name":"Institut de Recherche de Paris, INSERM UMRS-1160, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-8156","authenticated-orcid":false,"given":"Melissa","family":"Gamat-Huber","sequence":"additional","affiliation":[{"name":"UW Carbone Cancer Center, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Yonekura","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Ferrere","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Rauber","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Phuong","family":"Pham","sequence":"additional","affiliation":[{"name":"Parean Biotechnologies, Saint Malo, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Eudes","family":"Fahrner","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"},{"name":"Universit\u00e9 Paris-Saclay, Saint-Aubin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Pizzato","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ly","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Fidelle","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Mazzenga","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Alves","family":"Costa Silva","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"},{"name":"Universit\u00e9 Paris-Saclay, Saint-Aubin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Armanini","sequence":"additional","affiliation":[{"name":"Department CIBIO, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department CIBIO, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Asnicar","sequence":"additional","affiliation":[{"name":"Department CIBIO, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Daill\u00e8re","sequence":"additional","affiliation":[{"name":"Gustave Roussy, Villejuif, France"},{"name":"EverImmune Gustave Roussy Cancer Center, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Derosa","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"},{"name":"Center of Clinical Investistigations in Biotherapies of Cancer (CICBT), Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Richard","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9dicine, CHUM, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Routy","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9dicine, CHUM, Montreal, Qu\u00e9bec, Canada"},{"name":"CRCHUM, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Culine","sequence":"additional","affiliation":[{"name":"Medical Oncology, H\u00f4pital Saint-Louis, Paris, France"},{"name":"Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paule","family":"Opolon","sequence":"additional","affiliation":[{"name":"Department of Biology and Medical Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeric","family":"Silvin","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Ginhoux","sequence":"additional","affiliation":[{"name":"INSERM U1015, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[{"name":"Institut de Recherche Saint Louis, INSERM U1160, Universit\u00e9 de Paris, Paris, France"},{"name":"Laboratoire d'immunologie et d'histocompatibilit\u00e9, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1583-5794","authenticated-orcid":false,"given":"Nicola","family":"Segata","sequence":"additional","affiliation":[{"name":"Department CIBIO, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-6723","authenticated-orcid":false,"given":"Douglas G","family":"McNeel","sequence":"additional","affiliation":[{"name":"Medicine, University of Wisconsin Madison, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-9474","authenticated-orcid":false,"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Saint-Aubin, France"},{"name":"Department of Medical Oncology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"Gustave Roussy, Villejuif, France"},{"name":"Sorbonne Universit\u00e9 INSERM U1138, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[{"name":"Gustave Roussy Cancer Campus, Villejuif, France"},{"name":"Universit\u00e9 Paris-Saclay Facult\u00e9 de M\u00e9decine, Le Kremlin-Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"2025100313544411000_10.3.e004191.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040531","article-title":"Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol","volume":"11","author":"Beyer","year":"2021","journal-title":"BMJ Open"},{"key":"2025100313544411000_10.3.e004191.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103370","article-title":"Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype","volume":"163","author":"Tong","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025100313544411000_10.3.e004191.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00470-4"},{"key":"2025100313544411000_10.3.e004191.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00438-4"},{"key":"2025100313544411000_10.3.e004191.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2012.02924.x"},{"key":"2025100313544411000_10.3.e004191.6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/modpathol.2012.164","article-title":"CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer","volume":"26","author":"Davidsson","year":"2013","journal-title":"Mod Pathol"},{"key":"2025100313544411000_10.3.e004191.7","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22862"},{"key":"2025100313544411000_10.3.e004191.8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15384047.2016.1235666","article-title":"Tumor infiltrating T lymphocytes expressing FOXP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse","volume":"17","author":"Nardone","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"2025100313544411000_10.3.e004191.9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy","volume":"81","author":"Yang","year":"2021","journal-title":"Prostate"},{"key":"2025100313544411000_10.3.e004191.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2025100313544411000_10.3.e004191.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2025100313544411000_10.3.e004191.12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025100313544411000_10.3.e004191.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.11.009"},{"key":"2025100313544411000_10.3.e004191.14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050915"},{"key":"2025100313544411000_10.3.e004191.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402201"},{"key":"2025100313544411000_10.3.e004191.16","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911622","article-title":"Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress","volume":"12","author":"Humeau","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2025100313544411000_10.3.e004191.17","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0465"},{"key":"2025100313544411000_10.3.e004191.18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.753"},{"key":"2025100313544411000_10.3.e004191.19","article-title":"Combinatorial strategies for the induction of immunogenic cell death","volume":"6","author":"Bezu","year":"2015","journal-title":"Front Immunol"},{"key":"2025100313544411000_10.3.e004191.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.024"},{"key":"2025100313544411000_10.3.e004191.21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100008"},{"key":"2025100313544411000_10.3.e004191.22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrclinonc.2016.41","article-title":"Immunological off-target effects of imatinib","volume":"13","author":"Zitvogel","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"2025100313544411000_10.3.e004191.23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"2025100313544411000_10.3.e004191.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17644-0","article-title":"Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer","volume":"11","author":"Buqu\u00e9","year":"2020","journal-title":"Nat Commun"},{"key":"2025100313544411000_10.3.e004191.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.027"},{"key":"2025100313544411000_10.3.e004191.26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00484.2005"},{"key":"2025100313544411000_10.3.e004191.27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251140998"},{"key":"2025100313544411000_10.3.e004191.28","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0145"},{"key":"2025100313544411000_10.3.e004191.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2804"},{"key":"2025100313544411000_10.3.e004191.30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41571-021-00508-x","article-title":"Beneficial autoimmunity improves cancer prognosis","volume":"18","author":"Zitvogel","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2025100313544411000_10.3.e004191.31","doi-asserted-by":"publisher","DOI":"10.1210\/endo-109-4-1073"},{"key":"2025100313544411000_10.3.e004191.32","doi-asserted-by":"publisher","DOI":"10.1155\/2001\/17064"},{"key":"2025100313544411000_10.3.e004191.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00927-z"},{"key":"2025100313544411000_10.3.e004191.34","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6918"},{"key":"2025100313544411000_10.3.e004191.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0374-6"},{"key":"2025100313544411000_10.3.e004191.36","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0877"},{"key":"2025100313544411000_10.3.e004191.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0701"},{"key":"2025100313544411000_10.3.e004191.38","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"2025100313544411000_10.3.e004191.39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","article-title":"Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies","volume":"21","author":"Sfanos","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2025100313544411000_10.3.e004191.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18649-5"},{"key":"2025100313544411000_10.3.e004191.41","doi-asserted-by":"crossref","unstructured":"Wang LL , Wong CYP . A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy. Prostate Cancer Prostatic Dis 2021.doi:10.1038\/s41391-021-00360-1","DOI":"10.1038\/s41391-021-00360-1"},{"key":"2025100313544411000_10.3.e004191.42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3441"},{"key":"2025100313544411000_10.3.e004191.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0078"},{"key":"2025100313544411000_10.3.e004191.44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092187","article-title":"Immune checkpoint inhibitors in prostate cancer","volume":"13","author":"Venkatachalam","year":"2021","journal-title":"Cancers"},{"key":"2025100313544411000_10.3.e004191.45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"key":"2025100313544411000_10.3.e004191.46","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329"},{"key":"2025100313544411000_10.3.e004191.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0006-2"},{"key":"2025100313544411000_10.3.e004191.48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"2025100313544411000_10.3.e004191.49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240527"},{"key":"2025100313544411000_10.3.e004191.50","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2016-0130"},{"key":"2025100313544411000_10.3.e004191.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.009"},{"key":"2025100313544411000_10.3.e004191.52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10753-020-01348-0","article-title":"Short-Term Cohousing of sick with healthy or treated mice alleviates the inflammatory response and liver damage","volume":"44","author":"Shabat","year":"2021","journal-title":"Inflammation"},{"key":"2025100313544411000_10.3.e004191.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01224-2"},{"key":"2025100313544411000_10.3.e004191.54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s10517-014-2652-4","article-title":"Thymus in experimental carcinogenesis of the prostate gland","volume":"157","author":"Borodin","year":"2014","journal-title":"Bull Exp Biol Med"},{"key":"2025100313544411000_10.3.e004191.55","doi-asserted-by":"publisher","DOI":"10.1038\/360225a0"},{"key":"2025100313544411000_10.3.e004191.56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"2025100313544411000_10.3.e004191.57","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4236"},{"key":"2025100313544411000_10.3.e004191.58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/cells10010185","article-title":"Beneficial effects of Akkermansia muciniphila are not associated with major changes in the circulating Endocannabinoidome but linked to higher Mono-Palmitoyl-Glycerol levels as new PPAR\u03b1 agonists","volume":"10","author":"Depommier","year":"2021","journal-title":"Cells"},{"key":"2025100313544411000_10.3.e004191.59","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.18632\/aging.202739","article-title":"Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites","volume":"13","author":"Grajeda-Iglesias","year":"2021","journal-title":"Aging"},{"key":"2025100313544411000_10.3.e004191.60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","article-title":"Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice","volume":"6","author":"Yoon","year":"2021","journal-title":"Nat Microbiol"},{"key":"2025100313544411000_10.3.e004191.61","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002722"},{"key":"2025100313544411000_10.3.e004191.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.04.022"},{"key":"2025100313544411000_10.3.e004191.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.033"},{"key":"2025100313544411000_10.3.e004191.64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2020.11.034","article-title":"Hallmarks of health","volume":"184","author":"L\u00f3pez-Ot\u00edn","year":"2021","journal-title":"Cell"},{"key":"2025100313544411000_10.3.e004191.65","article-title":"Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis","author":"Yonekura","year":"2021","journal-title":"Cancer Discov"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2021-004191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:54:53Z","timestamp":1759524893000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2021-004191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,16]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/jitc-2021-004191"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2021-004191","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}